Linfeng Xian - Search Results

Year	Number of Results
2015	2
2019	1
2021	1
2022	2
2023	1
2024	0

1

Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer.

Xian L, Zhao P, Chen X, Wei Z, Ji H, Zhao J, Liu W, Li Z, Liu D, Han X, Qian Y, Dong H, Zhou X, Fan J, Zhu X, Yin J, Tan X, Jiang D, Yu H, Cao G. Xian L, et al. Cell Oncol (Dordr). 2022 Oct;45(5):1019-1036. doi: 10.1007/s13402-022-00707-3. Epub 2022 Aug 29. Cell Oncol (Dordr). 2022. PMID: 36036881

2

circGLS2 inhibits hepatocellular carcinoma recurrence via regulating hsa-miR-222-3p-PTEN-AKT signaling.

Chen X, Wu T, Xian L, Ma L, Li N, Liu W, Cai P, Tan X, Yin J, Cao G. Chen X, et al. Among authors: xian l. Signal Transduct Target Ther. 2023 Feb 17;8(1):67. doi: 10.1038/s41392-022-01275-6. Signal Transduct Target Ther. 2023. PMID: 36797228 Free PMC article. No abstract available.

3

circKCNN2 suppresses the recurrence of hepatocellular carcinoma at least partially via regulating miR-520c-3p/methyl-DNA-binding domain protein 2 axis.

Liu D, Liu W, Chen X, Yin J, Ma L, Liu M, Zhou X, Xian L, Li P, Tan X, Zhao J, Liao Y, Cao G. Liu D, et al. Among authors: xian l. Clin Transl Med. 2022 Jan;12(1):e662. doi: 10.1002/ctm2.662. Clin Transl Med. 2022. PMID: 35051313 Free PMC article.

4

Polyamines Involved in Regulating Self-Incompatibility in Apple.

Yu J, Wang B, Fan W, Fan S, Xu Y, Liu C, Lv T, Liu W, Wu L, Xian L, Li T. Yu J, et al. Among authors: xian l. Genes (Basel). 2021 Nov 15;12(11):1797. doi: 10.3390/genes12111797. Genes (Basel). 2021. PMID: 34828403 Free PMC article.

5

Radiation-driven lipid accumulation and dendritic cell dysfunction in cancer.

Gao F, Liu C, Guo J, Sun W, Xian L, Bai D, Liu H, Cheng Y, Li B, Cui J, Zhang C, Cai J. Gao F, et al. Among authors: xian l. Sci Rep. 2015 Apr 29;5:9613. doi: 10.1038/srep09613. Sci Rep. 2015. PMID: 25923834 Free PMC article.

6

Genetic Polymorphisms Predisposing the Interleukin 6-Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations.

Liu W, Wu J, Yang F, Ma L, Ni C, Hou X, Wang L, Xu A, Song J, Deng Y, Xian L, Li Z, Wang S, Chen X, Yin J, Han X, Li C, Zhao J, Cao G. Liu W, et al. Among authors: xian l. Clin Cancer Res. 2019 Sep 15;25(18):5525-5536. doi: 10.1158/1078-0432.CCR-18-3083. Epub 2019 May 31. Clin Cancer Res. 2019. PMID: 31152021

7

A critical role of toll-like receptor 2 (TLR2) and its' in vivo ligands in radio-resistance.

Gao F, Zhang C, Zhou C, Sun W, Liu X, Zhang P, Han J, Xian L, Bai D, Liu H, Cheng Y, Li B, Cui J, Cai J, Liu C. Gao F, et al. Among authors: xian l. Sci Rep. 2015 Aug 13;5:13004. doi: 10.1038/srep13004. Sci Rep. 2015. PMID: 26268450 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

7 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year